BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 15003448)

  • 1. Enhanced CPT sensitivity of yeast cells and selective relaxation of Ga14 motif-containing DNA by novel Gal4-topoisomerase I fusion proteins.
    Alessandri M; Beretta GL; Ferretti E; Mancia A; Khobta A; Capranico G
    J Mol Biol; 2004 Mar; 337(2):295-305. PubMed ID: 15003448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tethering a type IB topoisomerase to a DNA site by enzyme fusion to a heterologous site-selective DNA-binding protein domain.
    Beretta GL; Binaschi M; Zagni E; Capuani L; Capranico G
    Cancer Res; 1999 Aug; 59(15):3689-97. PubMed ID: 10446983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A specific transcriptional response of yeast cells to camptothecin dependent on the Swi4 and Mbp1 factors.
    Lotito L; Russo A; Bueno S; Chillemi G; Fogli MV; Capranico G
    Eur J Pharmacol; 2009 Jan; 603(1-3):29-36. PubMed ID: 19094980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of growth inhibition by GAL4-L kappa B-alpha in Saccharomyces cerevisiae.
    Morin PJ; Downs JA; Snodgrass AM; Gilmore TD
    Cell Growth Differ; 1995 Jul; 6(7):789-98. PubMed ID: 7547500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of topoisomerase I and RAD52 protein in yeast reveals new facets of the mechanism of action of bisdioxopiperazine compounds.
    van Hille B; Clerc X; Creighton AM; Hill BT
    Br J Cancer; 1999 Nov; 81(5):800-7. PubMed ID: 10555749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of biochemical and functional interactions of Htl1p, a putative component of the Saccharomyces cerevisiae, Rsc chromatin-remodeling complex.
    Florio C; Moscariello M; Ederle S; Fasano R; Lanzuolo C; Pulitzer JF
    Gene; 2007 Jun; 395(1-2):72-85. PubMed ID: 17400406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential control of transcription-induced and overall DNA supercoiling by eukaryotic topoisomerases in vitro.
    Wang Z; Dröge P
    EMBO J; 1996 Feb; 15(3):581-9. PubMed ID: 8599941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trapping of DNA topoisomerase I on nick-containing DNA in cell free extracts of Saccharomyces cerevisiae.
    Lebedeva N; Auffret Vander Kemp P; Bjornsti MA; Lavrik O; Boiteux S
    DNA Repair (Amst); 2006 Jul; 5(7):799-809. PubMed ID: 16713756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA topoisomerase I domain interactions impact enzyme activity and sensitivity to camptothecin.
    Wright CM; van der Merwe M; DeBrot AH; Bjornsti MA
    J Biol Chem; 2015 May; 290(19):12068-78. PubMed ID: 25795777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of camptothecin or TOP1 overexpression on genetic stability in Saccharomyces cerevisiae.
    Sloan R; Huang SN; Pommier Y; Jinks-Robertson S
    DNA Repair (Amst); 2017 Nov; 59():69-75. PubMed ID: 28961461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line.
    Urasaki Y; Laco GS; Pourquier P; Takebayashi Y; Kohlhagen G; Gioffre C; Zhang H; Chatterjee D; Pantazis P; Pommier Y
    Cancer Res; 2001 Mar; 61(5):1964-9. PubMed ID: 11280753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding site.
    Urasaki Y; Laco G; Takebayashi Y; Bailly C; Kohlhagen G; Pommier Y
    Cancer Res; 2001 Jan; 61(2):504-8. PubMed ID: 11212241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locking the DNA topoisomerase I protein clamp inhibits DNA rotation and induces cell lethality.
    Woo MH; Losasso C; Guo H; Pattarello L; Benedetti P; Bjornsti MA
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):13767-72. PubMed ID: 14585933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GAL4 is a substrate for caspases: implications for two-hybrid screening and other GAL4-based assays.
    van Criekinge W; Cornelis S; Van De Craen M; Vandenabeele P; Fiers W; Beyaert R
    Mol Cell Biol Res Commun; 1999 May; 1(2):158-61. PubMed ID: 10356366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential induction of topoisomerase I-DNA cleavage complexes by the indenoisoquinoline MJ-III-65 (NSC 706744) and camptothecin: base sequence analysis and activity against camptothecin-resistant topoisomerases I.
    Antony S; Jayaraman M; Laco G; Kohlhagen G; Kohn KW; Cushman M; Pommier Y
    Cancer Res; 2003 Nov; 63(21):7428-35. PubMed ID: 14612542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired camptothecin resistance of human breast cancer MCF-7/C4 cells with normal topoisomerase I and elevated DNA repair.
    Fujimori A; Gupta M; Hoki Y; Pommier Y
    Mol Pharmacol; 1996 Dec; 50(6):1472-8. PubMed ID: 8967967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rad52 and Rad59 exhibit both overlapping and distinct functions.
    Feng Q; Düring L; de Mayolo AA; Lettier G; Lisby M; Erdeniz N; Mortensen UH; Rothstein R
    DNA Repair (Amst); 2007 Jan; 6(1):27-37. PubMed ID: 16987715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA protein interactions at the rRNA of Saccharomyces cerevisiae.
    Cioci F; Di Felice F; Chiani F; Camilloni G
    Ital J Biochem; 2007 Jun; 56(2):81-90. PubMed ID: 17722648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine.
    Benedetti P; Fiorani P; Capuani L; Wang JC
    Cancer Res; 1993 Sep; 53(18):4343-8. PubMed ID: 8395982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repair of topoisomerase I covalent complexes in the absence of the tyrosyl-DNA phosphodiesterase Tdp1.
    Liu C; Pouliot JJ; Nash HA
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14970-5. PubMed ID: 12397185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.